Altimmune ALT
NASDAQ ALT
$2.17 -0.06 (-2.69%)
At close: Oct 22, 2026 · 4:00 PM EDT

Altimmune (ALT) Other Investing Activities (2017)

Updated

Analysis

Altimmune (ALT) Other Investing Activities (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other investing (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -127.00 Mn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 352.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -51.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -22.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 218.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 174.00 Mn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -56.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 20.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -1.00 Mn
10 Altimmune 422.01 Mn -720.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 200,000.00
API Access

Altimmune Other Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-investing-activities&ticker=ALT&period=max&api_key=YOUR_API_KEY